XML 33 R22.htm IDEA: XBRL DOCUMENT
v3.25.3

Segment Reporting (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2025
Segment Reporting [Abstract] |
Schedule of Reportable Segment Profit and Loss, Including Significant Expense Categories | The following table presents reportable segment profit and loss, including significant expense categories, attributable to our reportable segment for the three and nine months ended September 30, 2025 and 2024: Schedule of Reportable Segment Profit and Loss, Including Significant Expense Categories
|  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
|  | Three Months Ended September 30, |  |  | Nine Months Ended September 30, |
|  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
Preclinical, clinical trial and other costs |  | $ | 1,204,017 |  |  | $ | 1,850,812 |  |  | $ | 4,543,279 |  |  | $ | 4,143,813 |
Research and development personnel expense(1) |  |  | 457,629 |  |  |  | 436,713 |  |  |  | 1,153,412 |  |  |  | 1,412,881 |
General and administrative personnel expense(2) |  |  | 855,089 |  |  |  | 493,144 |  |  |  | 2,157,979 |  |  |  | 1,457,941 |
Administrative and facilities expense(3) |  |  | 972,108 |  |  |  | 644,184 |  |  |  | 2,431,946 |  |  |  | 2,301,840 |
Other income, net |  |  | (52,270 | ) |  |  | (40,150 | ) |  |  | (81,720 | ) |  |  | (195,065 | )
Total |  | $ | 3,436,573 |  |  | $ | 3,384,703 |  |  | $ | 10,204,896 |  |  | $ | 9,121,410 |
(1) | Research and development personnel costs include employee stock-based compensation expense of $110,239 and $54,018 for the three months ended September 30, 2025 and 2024, respectively, and $165,572 and $130,722 for the nine months ended September 30, 2025 and 2024, respectively.
(2) | General and administrative personnel costs include employee stock-based compensation expense of $192,808 and $53,725 for the three months ended September 30, 2025 and 2024, respectively, and $438,118 and $132,905 for the nine months ended September 30, 2025 and 2024, respectively, and are net of reimbursements received from CorLyst, LLC.
(3) | Administrative & facilities expense primarily consists of facilities expenses, office expenses, legal costs, insurance, consulting, travel, and other administrative costs.

X
- Definition Tabular disclosure of reconciliation of other items from reportable segments to their consolidated amount. Excludes reconciliation of revenue, profit (loss), and assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration